Kentucky 2026 Regular Session

Kentucky Senate Bill SB103

Introduced
1/16/26  

Caption

AN ACT relating to prescription drugs.

Impact

If enacted, SB103 will have significant implications on existing state health laws related to insurance and healthcare delivery. The objective is to create a more consumer-friendly environment, especially for those dependent on prescription medication. This modification could lead to lower out-of-pocket expenses for a substantial number of insured individuals and foster greater accessibility to affordable healthcare options, particularly for maintaining essential medications through both retail and mail-order pharmacies.

Summary

SB103 aims to amend regulations surrounding prescription drug coverage within health plans, enhancing the protection of insured individuals regarding drug pricing and pharmacy benefits. The bill introduces provisions to prevent insurers from charging insured individuals more in cost-sharing than the cash price for medications, thus promoting affordability and access to necessary drugs. Additionally, it enforces controls on pharmacy contracting, ensuring fair treatment in fees and reimbursement processes related to pharmacy services under health plans.

Sentiment

The sentiment surrounding SB103 appears largely positive among advocates for patient rights and affordability in healthcare. Proponents argue that the bill addresses long-standing issues regarding prescription drug pricing and enhances consumer protections in the health insurance marketplace. However, potential opposition may arise from stakeholders within the pharmaceutical and insurance industries, concerned that the regulatory changes might affect their pricing strategies and profit margins.

Contention

Some known points of contention include the potential financial impact on pharmacies and insurers if they are mandated to adhere to the new pricing structures and cost-sharing requirements laid out in the bill. Stakeholders worry that while the intent is to reduce costs for consumers, it could lead to changes in how drugs are priced and covered by providers, which may, in turn, affect the overall economic dynamics of the healthcare sector.

Companion Bills

No companion bills found.

Previously Filed As

KY HB413

AN ACT relating to prescription drugs.

KY SB12

AN ACT relating to prescription drugs.

KY HB389

AN ACT relating to prescription drugs.

KY HB614

AN ACT relating to professional dispensing fees for prescription drugs and declaring an emergency.

KY HB685

AN ACT relating to the 340B Drug Pricing Program.

KY HB572

AN ACT relating to psychotropic drugs.

KY HB793

AN ACT relating to reproductive health services.

KY HB691

AN ACT relating to coverage for the care of children.

KY HB423

AN ACT relating to prior authorization.

KY HB683

AN ACT relating to coverage for the treatment of postpartum mood disorders.

Similar Bills

No similar bills found.